![KMRK - K-Tech Solutions Company Ltd - Stock Price Chart]() |
Market Cap | - | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | - | Inst Own | - |
Insider Trans | - | Inst Trans | - |
Short Float | - | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 1.31M | 52W Range | 4.10 - 5.50 |
|
|
|
K-Tech Solutions Co., Ltd. is a holding company, which engages in the design, development, testing, and sale of a diverse portfolio of toy products. It offers plastic toys, electromechanical toys, infant and pre-school educational toys, and learning kits. The company was founded in 2016 and is headquartered in Hong Kong. |
|
 |
![SRPT - Sarepta Therapeutics Inc - Stock Price Chart]() |
Market Cap | 1.38B | EPS (ttm) | -2.58 |
P/E | - | EPS this Y | -256.61% |
Forward P/E | 3.83 | EPS next Y | 207.50% |
PEG | - | EPS past 5Y | - |
P/S | 0.62 | EPS next 5Y | 16.97% |
P/B | 1.21 | EPS Q/Q | -1361.33% |
Dividend | - | Sales Q/Q | 80.15% |
Insider Own | 4.89% | Inst Own | 90.26% |
Insider Trans | -0.05% | Inst Trans | -0.90% |
Short Float | 15.71% | Earnings | May 06/a |
Analyst Recom | 2.30 | Target Price | 43.00 |
Avg Volume | 5.91M | 52W Range | 16.88 - 150.48 |
|
|
Today | Downgrade |
Needham |
Buy → Hold |
|
|
Today 07:54PM
|
Sarepta Refused FDAs Request to Halt Elevidys Shipments
(Bloomberg) -35.94% |
07:39PM
|
Sarepta Therapeutics Provides Statement on ELEVIDYS
(Business Wire) |
06:42PM
|
Sarepta Therapeutics Stock Plunges After Another Patient Death Is Linked to One of Its Gene Therapies
(The Wall Street Journal) |
05:57PM
|
Third Fatal Liver Failure Hits Sarepta Gene Trial
(GuruFocus.com) |
04:32PM
|
These Stocks Moved the Most Today: Netflix, Sarepta, Amex, Norfolk Southern, Interactive Brokers, Talen, Schwab, and More
(Barrons.com) |
04:17PM
|
The FDA Will Reportedly Ask Sarepta To Stop Selling Elevidys. Shares Plummet.
(Investor's Business Daily) |
03:49PM
|
Investors Urged to Contact Levi & Korsinsky for Information Before August 25, 2025 - Sarepta Therapeutics, Inc. (SRPT)
(Newsfile) |
02:58PM
|
Sarepta Shares Crash on Report That FDA Will Ask It to Stop Shipping Key Drug
(Barrons.com) |
02:24PM
|
These Stocks Are Moving the Most Today: Netflix, Sarepta, Amex, Norfolk Southern, Interactive Brokers, Talen, Schwab, and More
(Barrons.com) |
01:38PM
|
Top Stock Movers Now: Invesco, Talen Energy, Norfolk Southern, and More
(Investopedia) |
|
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Barry Richard | Director | May 16 '25 | Option Exercise | 32.63 | 12,350 | 402,981 | 2,966,667 | May 19 07:32 AM | Barry Richard | Director | May 13 '25 | Option Exercise | 19.23 | 20,246 | 389,359 | 2,954,317 | May 15 07:00 AM | Nicaise Claude | Director | Mar 12 '25 | Option Exercise | 25.18 | 9,746 | 245,404 | 30,303 | Mar 13 08:00 PM | Nicaise Claude | Director | Mar 12 '25 | Sale | 99.64 | 2,491 | 248,203 | 27,812 | Mar 13 08:00 PM | Nicaise Claude | Director | Mar 12 '25 | Proposed Sale | 99.65 | 2,491 | 248,226 | | Mar 12 05:33 PM |
|
|
 |
![GVH - Globavend Holdings Ltd - Stock Price Chart]() |
Market Cap | 0.52M | EPS (ttm) | 0.06 |
P/E | 0.58 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.05 | EPS next 5Y | - |
P/B | 0.15 | EPS Q/Q | -37.97% |
Dividend | - | Sales Q/Q | -10.78% |
Insider Own | 76.65% | Inst Own | 12.51% |
Insider Trans | 0.00% | Inst Trans | 496.24% |
Short Float | 45.26% | Earnings | May 28 |
Analyst Recom | 1.00 | Target Price | 0.40 |
Avg Volume | 39.24M | 52W Range | 0.04 - 1.82 |
|
|
|
Globavend Holdings Ltd. is an e-commerce logistics provider offering end-to-end logistics solutions in Hong Kong, Australia, and New Zealand. The company's customers are primarily enterprise customers, e-commerce merchants, or operators of e-commerce platforms that offer business-to-consumer (B2C) transactions. It offers a one-stop solution, from pre-carriage parcel drop-off to parcel consolidation, air-freight forwarding, customs clearance, on-carriage parcel transportation, and delivery. The company was founded by Yau Wai Yiu in 2016 and is headquartered in Perth, Australia. |
|
|  |
![HBNB - Hotel101 Global Holdings Corp - Stock Price Chart]() |
Market Cap | 508.11M | EPS (ttm) | 0.27 |
P/E | 7.98 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 0.27 | EPS Q/Q | 25.99% |
Dividend | - | Sales Q/Q | - |
Insider Own | 27.25% | Inst Own | 1.75% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.01% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 219.87K | 52W Range | 2.38 - 19.28 |
|
|
|
Hotel101 Global Holdings Corp. engages in the development and sale of real estate and hotel units. The company was founded by Edgar J. Sia II and Tony Tan Caktiong on March 13, 2024 and is headquartered in Singapore. |
|
 |
![MULN - Mullen Automotive Inc - Stock Price Chart]() |
Market Cap | 0.94M | EPS (ttm) | -505005847.62 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 79.12% |
P/S | 0.11 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 100.00% |
Dividend | - | Sales Q/Q | 14749.68% |
Insider Own | 0.00% | Inst Own | 0.00% |
Insider Trans | - | Inst Trans | 0.03% |
Short Float | 16.83% | Earnings | - |
Analyst Recom | - | Target Price | 25.00 |
Avg Volume | 20.18M | 52W Range | 0.10 - 106800000.00 |
|
|
|
Mullen Automotive Inc. operates as an electric vehicle company, which engages in the manufacture of passenger electric vehicles and commercial vehicles. It operates through the Bollinger and Mullen/ELMS segments. The company was founded by David Michery on April 20, 2010 and is headquartered in Brea, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
PUCKETT KENT | Director | Jun 10 '25 | Sale | 5.92 | 21,000 | 124,261 | 1 | Jun 17 05:47 PM | HRT FINANCIAL LP | 10% Owner | Apr 03 '25 | Buy | 0.08 | 546,706 | 43,736 | 665,392 | Apr 08 10:41 AM | HRT FINANCIAL LP | 10% Owner | Apr 04 '25 | Sale | 0.08 | 2,012,436 | 160,995 | 1,347,044 | Apr 08 10:41 AM | WINTER MARY | Director | Mar 05 '25 | Sale | 2.01 | 62,000 | 124,620 | 0 | Mar 06 05:15 PM | WINTER MARY | Director | Feb 27 '25 | Sale | 3.73 | 2,716 | 10,131 | 0 | Feb 28 05:16 PM |
|
|
|  |
![FOXO - FOXO Technologies Inc - Stock Price Chart]() |
Market Cap | 2.12M | EPS (ttm) | -7.93 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -7.61% |
P/S | 0.29 | EPS next 5Y | - |
P/B | 0.04 | EPS Q/Q | 84.81% |
Dividend | - | Sales Q/Q | 39918.93% |
Insider Own | 0.75% | Inst Own | 0.24% |
Insider Trans | 0.00% | Inst Trans | 0.27% |
Short Float | 1.31% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 7.33M | 52W Range | 0.12 - 13.00 |
|
|
|
FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. It operates through the FOXO Labs and FOXO Life segments. The FOXO Labs segment is involved in research and development and is commercializing proprietary epigenetic biomarker technology. The FOXO Life segment is involved in combining life insurance with a dynamic molecular health and wellness platform. The company was founded on April 27, 2020 and is headquartered in West Palm Beach, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Kr8 ai Inc. | 10% Owner | Jul 22 '24 | Sale | 0.25 | 1,300,000 | 325,000 | 0 | Jul 24 04:00 PM | WHITE MARK BRIAN | Interim CEO | Jul 22 '24 | Sale | 0.25 | 1,300,000 | 325,000 | 0 | Jul 24 04:00 PM | WARD MARTIN CHRISTOPHER | Interim CFO | Jul 22 '24 | Sale | 0.25 | 1,300,000 | 325,000 | 0 | Jul 24 04:00 PM |
|
|
 |
![XXII - 22nd Century Group Inc - Stock Price Chart]() |
Market Cap | 1.96M | EPS (ttm) | -2825.51 |
P/E | - | EPS this Y | 99.23% |
Forward P/E | 0.77 | EPS next Y | 126.83% |
PEG | - | EPS past 5Y | 52.01% |
P/S | 0.08 | EPS next 5Y | - |
P/B | 0.13 | EPS Q/Q | 99.37% |
Dividend | - | Sales Q/Q | -7.93% |
Insider Own | 20.04% | Inst Own | 2.20% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 11.78% | Earnings | May 13/b |
Analyst Recom | 2.00 | Target Price | 63.25 |
Avg Volume | 504.13K | 52W Range | 4.24 - 2822.45 |
|
|
|
22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Mocksville, NC. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
FIRESTONE LAWRENCE | Chief Executive Officer | Sep 12 '24 | Buy | 0.27 | 39,000 | 10,468 | 54,250 | Sep 12 05:00 PM |
|
|
|  |
![ENOV - Enovis Corp - Stock Price Chart]() |
Market Cap | 1.50B | EPS (ttm) | -14.48 |
P/E | - | EPS this Y | 6.89% |
Forward P/E | 7.70 | EPS next Y | 12.51% |
PEG | - | EPS past 5Y | -4.65% |
P/S | 0.70 | EPS next 5Y | 11.76% |
P/B | 0.57 | EPS Q/Q | 25.15% |
Dividend | - | Sales Q/Q | 8.25% |
Insider Own | 2.13% | Inst Own | 104.60% |
Insider Trans | 0.00% | Inst Trans | -4.84% |
Short Float | 14.18% | Earnings | Aug 07/b |
Analyst Recom | 1.27 | Target Price | 56.30 |
Avg Volume | 1.35M | 52W Range | 28.83 - 49.83 |
|
|
|
Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE. |
|
 |
![MOH - Molina Healthcare Inc - Stock Price Chart]() |
Market Cap | 9.92B | EPS (ttm) | 20.70 |
P/E | 8.84 | EPS this Y | -0.25% |
Forward P/E | 6.99 | EPS next Y | 15.89% |
PEG | 0.99 | EPS past 5Y | 12.22% |
P/S | 0.24 | EPS next 5Y | 8.93% |
P/B | 2.29 | EPS Q/Q | 5.33% |
Dividend | - | Sales Q/Q | 12.24% |
Insider Own | 1.24% | Inst Own | 99.65% |
Insider Trans | -12.00% | Inst Trans | 1.45% |
Short Float | 2.18% | Earnings | Jul 23/a |
Analyst Recom | 2.40 | Target Price | 302.13 |
Avg Volume | 783.14K | 52W Range | 200.63 - 365.23 |
|
|
|
Molina Healthcare, Inc. engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
WOLF DALE B | Director | May 21 '25 | Sale | 322.89 | 1,500 | 484,328 | 14,209 | May 22 04:39 PM | THE DALE B. WOLF REVOCABLE TRU | Director | May 21 '25 | Proposed Sale | 322.88 | 1,500 | 484,323 | | May 21 04:17 PM | ORLANDO STEVEN J | Director | May 05 '25 | Sale | 318.58 | 1,000 | 318,580 | 16,543 | May 05 04:36 PM | Zubretsky Joseph M | President & CEO | Apr 30 '25 | Sale | 320.06 | 87,500 | 28,005,170 | 257,715 | May 02 04:34 PM | ORLANDO STEVEN J | Director | May 05 '25 | Proposed Sale | 315.00 | 1,000 | 315,000 | | May 02 04:22 PM |
|
|
 |
![LAWR - Robot Consulting Co Ltd. ADR - Stock Price Chart]() |
Market Cap | - | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | - | Inst Own | - |
Insider Trans | - | Inst Trans | - |
Short Float | - | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 1.91M | 52W Range | 3.50 - 4.39 |
|
|
|
Robot Consulting is a platform service provider focusing on human resource solutions with an intention to expand into legal technology and the metaverse. Our current major product is "Labor Robot," a cloud-based human resource management system launched in September 2022.Labor Robot helps users track employee attendance and sales orders and journalize accounting items. Additionally, we provide the information relating to grant (Joseikin) applications with MHLW and subsidy (Hojokin) applications with METI.Labor Robot users are the users of Labor Robot who directly purchase Labor Robot from us and the users who purchase it from Nac Co., Ltd, a Japanese conglomerate. |
|
|